A wearable biosensor developed by Washington State University researchers could improve wireless glucose monitoring for people with diabetes, making it more cost-effective, accurate, and less invasive ...

Dexcom is continuing to evolve Stelo beyond basic glucose tracking, announcing a new wave of AI-powered features designed to help users better understand how food and daily habits affect their ...

Dexcom DXCM recently announced an upcoming nationwide rollout of an AI-driven upgrade to its Stelo platform aimed at improving users’ understanding of glucose health and supporting long-term wellness ...

Dexcom, Inc. (Nasdaq:DXCM), the global leader in glucose biosensing, announced it will roll out an advanced AI-enabled enhancement to Stelo that will transform how users understand their glucose ...

Enhanced Smart Food Logging experience now provides nutritional breakdown of meals Advanced AI-enabled features will deliver easy meal tracking to transform daily metabolic health management ...

Diabetes is incredibly common. According to the American Diabetes Association, around 7 million people in the United States are undiagnosed, with 1 in 3 Americans at risk for developing type 2 ...

A portable biosensor developed at La Trobe University may allow rapid, on-site detection of toxic "forever chemicals" in water, removing the need for samples to be sent to specialist laboratories. The ...

We look into the mental health crisis affecting American youth. By Sam Sifton I am the host of The Morning. The numbers are staggering. Nearly one in four 17-year-old boys in the United States has ...

These two medical device makers have seen huge success in their areas of specialty. DexCom has a profitable and growing CGM business, and its addressable market is expanding. Abbott sells ...

If you are a new investor, healthcare stocks can provide numerous diversification benefits to your portfolio and help enhance its returns in the long run. Healthcare stocks have historically displayed ...

DexCom beat expectations in the third quarter, and it raised its revenue guidance for the full year. Manufacturing issues are putting pressure on margins. For 2026, the company sees growth missing ...